Regulators oversee every aspect of drug development — from preclinical testing and toxicology studies to clinical trials, approval, commercialization and marketing. Our pharmaceutical regulation webinars keep you current with the latest changes from the FDA, EMA and other global agencies.

Embracing New Technologies
Electronic data collection methods like eConsent push clinical researchers to explore new ways to meet compliance. Decentralized and virtual clinical trials now face unique challenges that our webinars address.

Streamlining IRB Processes
Institutional review boards now operate under complex, changing regulations. Our webinars offer strategies to simplify IRB submissions and keep trials on track.

Navigating Biologic and Combination Regulations
Biologic drugs — such as vaccines, monoclonal antibodies, and immunotherapies — face stricter guidelines than traditional drugs. We cover FDA guidance on GMP for biologics and biosimilar classifications. We also explore regulations for combination products that merge drugs and devices, as well as rare and orphan drug products.

Scroll down to discover the latest in pharmaceutical regulation with our comprehensive webinar series.